The meeting will address relevant topics on the thyroidfield, including advances in research, bringing together doctors from several countries


Between June 15th and 18th, the Windsor Barra Convention Center in Rio de Janeiro hosts the sixteenth edition of the Latin American Thyroid Congress. During the meeting, which will be held for the second time in the city, experts will discuss new approaches in the treatment of thyroid cancer, thyroid orbitopathy, surgery for toxic nodular goiter, among others, with the presence of dozens of speakers from various parts of the Latin America, and the participation of seven guests from the United States, France, Portugal, Greece and Italy.


The president of LATS, Denise Carvalho, explains that the careful choice of the themes intend to promote the updating of the endocrinologists regarding the worldwide advances in each area. "We will look at issues of great relevance in the thyroid area that will be discussed by renowned national and international experts", she said. On the other hand, the president of the Local Committee, Mário Vaisman, emphasizes that the main diseases of the thyroid will be presented, including clinical and basic topics.


The first day's scientific programming includes two practical courses, a plenary session, and case discussion. In the following days, the scientific schedule includes symposia, satellite symposia, oral sessions, meet the professor, conferences and poster sessions, in a total of more than one hundred activities.


Among the hot topics mentioned by Denise Carvalho are "Approach to advanced differentiated carcinoma, thyroid and gestation, conceptual changes in thyroid nodular pathology, among others." Scientific Committee Chair Gabriela Brenta says that "some of the activities are planned to stimulate the participation of younger researchers in discussing clinical cases and debates."


All presentations will be in Portuguese, Spanish and English. The LATS Congress is held every two years in a Latin American country, so that all experts in the area are reached in the exchange of experiences and knowledge.


Inscriptions are open. The first deadline for late payment ends on March 15th. Access and secure your place:


Scientific Study


Scientific studies for evaluation should be submitted exclusively through the Internet, until March 27th. Before submitting, the author must be registered in the system. After registering, the author must log in and can submit the study (oral or poster), obeying the specific rules of the abstract format. After submitting the summary and completing the online form, the authors will receive an email confirming the information provided.

Published in MAR 8, 2017 Mais notícias.

New evidence-based recommendations from the American Thyroid Association (ATA) provide guidance to clinicians in diagnosing and managing thyroid disease during pregnancy and the postpartum period. Pregnancy has a profound effect on thyroid gland function, and thyroid disease is common in pregnancy. The 97 recommendations presented in the new Guidelines help define current best practices for thyroid function testing, iodine nutrition, pregnancy complications, and treatment of thyroid disease during pregnancy and lactation. The American Thyroid Association (ATA) guidelines are available free on the website of Thyroid, the official peer-reviewed journal of the ATA, published by Mary Ann Liebert, Inc., publishers.

The “2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum” were coauthored by an international task force of expert clinicians and researchers in the field of thyroidology. Led by Co-chairs Erik Alexander MD, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA and Elizabeth Pearce, MD, MSc, Boston University School of Medicine, the task force provides a solid foundation of knowledge on the assessment and treatment of thyroid disease in women during pregnancy, preconception, and the postpartum period. The Guidelines include recommendations related to the diagnosis and management of hypothyroidism, thyrotoxicosis, thyroid nodules, and thyroid cancer, as well as thyroid considerations in infertile women, fetal and neonatal considerations, and directions for future research.

“These guidelines provide a superb overview on the pathophysiology and the clinical management of thyroid disorders during and after pregnancy. In addition, they also define areas where additional research is needed; this will allow keeping the document living with further updates in the coming years,” says Peter A. Kopp, MD, Editor-in-Chief of Thyroid and Professor of Medicine, Division of Endocrinology, Metabolism, and Molecular Medicine, Northwestern University Feinberg School of Medicine, Chicago.

“Produced by an international panel of recognized experts, these updated guidelines add to the library of similar documents on thyroid disease that serve as the gold standard for diagnosis and management of thyroid disorders and identify critical areas where more research and knowledge is needed,” says, John C. Morris, III, MD, President of the ATA, Mayo Clinic, Rochester, MN.

“With an estimated 300,000 pregnancies impacted by thyroid disease in the United States annually, these guidelines coalesce the best available evidence into clear clinical recommendations, and will improve the health of many, many mothers and newborns alike,” say Dr. Alexander and Dr. Pearce.


Published in FEV 10, 2017 Mais notícias.

Dear Colleagues,


It is with great pleasure that we invite all to participate in the XVI Latin American Thyroid Association Congress, which takes place in June 15 - 18, 2017, at the Windsor Barra Convention Center, in Rio de Janeiro. This will be the largest and most comprehensive event on the Thyroid field in Latin America.


We all know the difficulties that this multidisciplinary area ensures in both scientific and practical means, so we have organized, together with the Scientific committee, an event with a broad focus on the major thyroid pathologies, involving both basic and clinical topics.


On behalf of myself and the organizing committee, I am pleased to receive in Rio de Janeiro prominent international speakers in the field and count on the participation and engagement of all of you, so that our great mission contributes to the growth, enhancement of thyroid research in Latin America, and to the best assisted care to our patients.


I wish you all a great congress and hope you enjoy our beautiful city!


Welcome to Rio!! 

Mario Vaisman
Local Committee President



Dear Friends,


It is my biggest pleasure to invite you to Rio, one of the most wonderful cities ever, to attend the XVI Latin American Thyroid Society (LATS) Congress from 15-18th June 2017.


The reason I am inviting you to join us is because in this meeting you will be able to breathe the essence of the Thyroid research in Latin America.


The Scientific Committee has been working hard throughout this year to come up with a marvelous program which intends to cover the whole spectrum of clinical, translational and basic research. For this purpose the most relevant and trendy topics will be presented by researchers from our Latin American countries that are specialized on each of these fields.


The participation of 7 opinion leaders from Europe and USA will highlight this program and also give you the opportunity of a direct interaction with them.  


Furthermore, some of the activities are planned to boost the participation of younger investigators in the discussion of clinical cases and debates.


This Congress also has the aim to strengthen our Latin American bonds and enable the communication among us in the midst of a delightful ambiance.


On behalf of the whole Scientific Committee we are really looking forward to meet you in Rio for the XVI LATS Congress.


Gabriela Brenta
President of the Scientific Committee

Published in JAN 23, 2017 Mais notícias.

Recently, several media outlets have reported that mammography and X-rays increase the risk of thyroid cancer. The statements, circulated during the Brazilian " Rosa October ", which is the breast cancer awareness month in Brazil, generated many doubts and concerns about the need to use a thyroid protector during mammography.


Thus, we have to reaffirm that there are no consistent studies or statistics demonstrating that a woman undergoing mammography has a higher risk of thyroid cancer. There might be other factors involved in the increased rate of this type of tumor, such as environmental factors. Several published studies show that mammography does not expose the thyroid to harmful X-rays doses. The radiation dose to the thyroid during a mammogram is extremely low, less than 1% of the dose received by the breast, and the radiation emitted by the environment at the time of the examination is higher than this dose.

LATS points out that the use of a thyroid protector is not recommended for mammography. This position is in agreement with other national entities (Brazilian College of Radiology, Brazilian Society of Mastology and the Brazilian Federation of Gynecology and Obstetrics Associations) and international institutions such as the American College of Radiology, American Society for Breast Disease, American Thyroid Association and International Atomic Energy Agency.

"It is important to perform routine screening, such as mammography from the age of 40, which is the most important way to detect early breast cancer. There is no reason to say that mammography causes a thyroid cancer, "concludes LATS President Denise Carvalho.

Published in NOV 25, 2016 Mais notícias.

LATS Eletronic Journal

LATS Eletronic Journal

Available the last edition of the Journal LATS.

  • Portuguese Version
  • Spanish Version